Skip to Content

Sufentanil Pregnancy and Breastfeeding Warnings

Sufentanil is also known as: Sufenta

Sufentanil Pregnancy Warnings

Benefit should outweigh risk US FDA pregnancy category: Not Assigned Risk Summary: Available data in pregnant women are insufficient to inform a drug-associated risk for major birth defects and miscarriage; prolonged use during pregnancy may cause neonatal opioid withdrawal syndrome. Comments: -Neonates exposed to opioid analgesics during labor should be monitored for signs of excess sedation and respiratory depression. -Prolonged maternal use of opioids during pregnancy can result in physical dependence in the neonate and neonatal opioid withdrawal syndrome shortly after birth. -Sublingual use should be avoided during pregnancy and in women of childbearing potential not using contraception

Embryolethality and maternal toxicity were observed in rats given IV doses of 0.9 times the human procedural dose during organogenesis. This drug rapidly crosses the placenta and may produce respiratory depression in the neonate; IV use is generally not recommended during or immediately prior to labor when other analgesic techniques are more appropriate. Epidural use during labor and delivery has been used although high doses should be avoided because of potential risks to the newborn infant after delivery. As with other narcotics, opioid effects can be quickly reversed with naloxone. There are no adequate and well controlled studies in pregnant women. US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D, and X are being phased out.

See references

Sufentanil Breastfeeding Warnings

Epidural use during labor or for a short-time immediately postpartum is not expected to cause adverse effects in breastfed infants. Use may delay onset of lactation, however with good breastfeeding support, epidural use is expected to have little to no effect on breastfeeding success. There is no data on IV use of this drug during established lactation, other agents may be preferred

US (IV, epidural): Benefit should outweigh risk UK (sublingual): Not recommended Excreted into human milk: Yes Comments: -Breastfed infants should be monitored for excess sedation and respiratory depression.

See references

References for pregnancy information

  1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  2. "Product Information. SUFentanil Citrate (SUFentanil)." Akorn Inc, Buffalo Grove, IL.

References for breastfeeding information

  1. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL:" ([cited 2013 -]):
  2. "Product Information. SUFentanil Citrate (SUFentanil)." Akorn Inc, Buffalo Grove, IL.
  3. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.